Stock 4552 JCR PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
622 JPY +0.97% Intraday chart for JCR Pharmaceuticals Co., Ltd. -22.15% -46.93%
04-25 JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024 CI
03-21 US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JCR Pharmaceuticals : FY2023 Second Half Results Briefing Session Script （2,257KB）
PU
JCR Pharmaceuticals : FY2023 Results Briefing Session -Material-（1,196KB）
PU
JCR Pharmaceuticals : Appendix to the Consolidated Financial Summary FY2023 Second-Half (Flash report)（1,091KB）
PU
JCR Pharmaceuticals Co., Ltd. Announces Dividend for the Year Ended March 31, 2024, Payable on June 27, 2024
CI
JCR Pharmaceuticals Co., Ltd. Announces Management Changes, Effective as of June 26, 2024
CI
Final dividend
FA
US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak
MT
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion
MT
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion
AQ
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
BU
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion
CI
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index
CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd
CI
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
BU
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes
CI
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders
AQ
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
BU
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier
CI
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
CI
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4552 Stock
  4. News JCR Pharmaceuticals Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW